Article Information
History
- August 4, 2024.
Article Versions
- Version 1 (August 2, 2024 - 10:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Takashi Yoshioka, MD, PhD1,2,*,
- Kenji Omae, MD, DrPH3,4,
- Satoshi Funada, MD, PhD1,
- Tetsuji Minami, MD, PhD5 and
- Rei Goto, MD, PhD6,7
- 1Health Technology Assessment Unit, Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan
- 2Institute of Clinical Epidemiology, Showa University, Tokyo, Japan
- 3Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan
- 4Department of Health Promotion and Human Behavior, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto, Japan
- 5Division of Quality Assurance Programs, Institute for Cancer Control, National Cancer Center, Tokyo, Japan
- 6Graduate School of Health Management, Keio University, Kanagawa, Japan
- 7Graduate School of Business Administration, Keio University, Kanagawa, Japan
- ↵*Corresponding author:
Takashi Yoshioka, Health Technology Assessment Unit, Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan Tel:+81-3-5363-3205, E-mail: ty5733{at}keio.jp
Posted August 04, 2024.
